
DisainaM
Senior Member
Themenstarter
durch die Suche nach neuen Medikamenten sind bald alle Affen in China aufgebraucht,
und man ist gezwungen, grosse Stückzahlen zu Importieren.
und man ist gezwungen, grosse Stückzahlen zu Importieren.
China's vaccine race: shortage of monkeys and working weekendstest it on monkeys, which have become expensive due to high demand from labs testing an array of Covid-19 antibody drugs and vaccines, according to Yisheng chief executive David Shao.
Yisheng used to pay between 10,000 and 20,000 yuan (43,700 to 87,400 baht) each for macaques, Shao said.
Now each animal is worth 100,000 yuan, according to Shao.
Chinese labs mainly use rhesus and cynomolgus macaques, farmed in the country's southern provinces.
China is a large provider of lab monkeys, exporting 20,000 of them last year and using 18,000 in local research, said Liu Yunbo, chairman of Beijing HFK Bioscience, a lab animal provider.
"This year's consumption is quite large, so the supply is not enough," he said.
- 'Racing for time' -
Yisheng has spent about US$3 million on its vaccine research so far, with plans to start production in a few months and make it available to the public this year.
"It's more expensive than other vaccine products," Shao said, adding that there was a shortage of resources and research material.
"We are really racing for time."
The company plans to spend another $180 million for the clinical trials following the animal tests.
"We can have as many as 10 production lines and produce 500 million doses a year," Zhang said.
With too few infections now in China to test the vaccine on humans, Yisheng plans to apply for clinical trials in the United States, Europe, Singapore and Australia in collaboration with a US company.
Ten clinical trials are taking place around the world, half of them in China.
Zhang said competitors were likely to beat his company in the race to produce the first vaccine, but that was not his priority.
"It's about who can produce the quantity. Who can get good results and make a high quality and effective product, he said.
"This is what really counts. Being first doesn't mean anything."
- 0
- 0